Have you heard about the latest clinical advances in AML therapy? Recent approvals and emerging therapies, such as epigenetic agents and newer cytotoxics, has transformed the care of patients with newly diagnosed and relapsed/refractory AML.

Join Dr Stephen A. Strickland and Dr Eunice S. Wang as they discuss recent science that provides guidance for the care team on the use of newly approved and novel strategies for AML management.

Click here to listen to this 45-minute CME podcast:

https://www.mycme.com/courses/new-therapeutic-options-in-aml-an-update-for-community-clinicians-7573